This Article Abstract Full Text Full Text (PDF) View Current Clinical Collection-Atrial Fibrillation View Genuine Article Video Part Two View CVN News Brief Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (28) Citing Articles via Google Scholar Google Scholar Articles by Ruiz-Nodar, J. M. Articles by Lip, G. Y.H. Search for Related Content PubMed Articles by Ruiz-Nodar, J. M. Articles by Lip, G. Y.H. Related Collections Related Articles

Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation

Implications for Bleeding Risk and Prognosis

Juan M. Ruiz-Nodar, MD, PhD^_*, Francisco Marín, MD, PhD^,, José Antonio Hurtado, MD^,, José Valencia, MD, PhD^_*, Eduardo Pinar, MD, PhD^,, Javier Pineda, MD, PhD^_*, Juan Ramón Gimeno, MD, PhD^,, Francisco Sogorb, MD, PhD^_*, Mariano Valdés, MD, PhD and Gregory Y.H. Lip, MD, FACC, FESC^,_*

^_* Department of Cardiology, Hospital General Universitario de Alicante, Alicante, Spain
Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
Red de Investigación Cardiovascular RECAVA, Instituto Salud Carlos III, Madrid, Spain
University Department of Medicine, City Hospital, Birmingham, United Kingdom.

View larger version (11K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Kaplan-Meier Survival Curves in Relation to Anticoagulation Use at Discharge Patients were stratified according to anticoagulation use at discharge compared to non-use. (A) Major bleeding: log-rank test, p = 0.6; (B) major adverse cardiovascular events: log-rank test, p = 0.02; and (C) all-cause mortality: log-rank test, p = 0.03. Number of patients followed: anticoagulation group, n = 195; no-anticoagulation group, n = 178. Dotted lines = no anticoagulation use at discharge; solid lines = anticoagulation use at discharge.